LINK4HEALTH
Status:Completed
Phase:Open Label
Principal Investigator(s):Wafaa M El-Sadr & Margaret McNairy
Objective:This study's aim is to improve linkage to HIV care and retention in HIV care through the use of feasible, evidence-based, and practical interventions. The study takes place in Swaziland, the country with the highest HIV prevalence (24%) in sub-Saharan Africa. The study will randomize groups of HIV testing sites and affiliated clinics to either standard of care or a combined intervention strategy (CIS) which consists of point-of care CD4 (cluster differentiation 4 (CD4)) testing at time of HIV testing, fast-track HIV medications for those who are eligible for treatment,mobile phone appointment reminders, care bags filled with health prevention materials, and financial incentives. The study outcomes are linkage to and retention in care as well as cost effectiveness, feasibility of interventions, and patient acceptability of interventions.Last updated September 8, 2022
Prevention Option(s):Treatment U=U
Study Design:Controlled, Open label, Randomized
Official Code:
NCT01904994
Trial Sponsors:
CDC, Columbia University, New York University, NIAID, NIH
Start Date
End Date
August 31, 2013
October 21, 2021
Enrollment:2,201
Age range:
18 Years ↔
any
Population:Cisgender Men, Cisgender Women, People Living with HIV